tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Hold Rating on Vigil Neuroscience Inc Amidst Acquisition and Trial Outcomes
PremiumRatingsHold Rating on Vigil Neuroscience Inc Amidst Acquisition and Trial Outcomes
3M ago
Vigil Neuroscience provides update on Phase 2 IGNITE trial of iluzanebart
Premium
The Fly
Vigil Neuroscience provides update on Phase 2 IGNITE trial of iluzanebart
3M ago
Vigil Neuroscience downgraded to Hold from Buy at Stifel
Premium
The Fly
Vigil Neuroscience downgraded to Hold from Buy at Stifel
4M ago
Vigil Neuroscience downgraded to Hold from Buy at Jefferies
PremiumThe FlyVigil Neuroscience downgraded to Hold from Buy at Jefferies
4M ago
Vigil Neuroscience downgraded to Neutral from Outperform at Wedbush
Premium
The Fly
Vigil Neuroscience downgraded to Neutral from Outperform at Wedbush
4M ago
Vigil Neuroscience Enters Merger Agreement with Sanofi
Premium
Company Announcements
Vigil Neuroscience Enters Merger Agreement with Sanofi
4M ago
Vigil Neuroscience Inc trading halted, news pending
PremiumThe FlyVigil Neuroscience Inc trading halted, news pending
4M ago
Vigil Neuroscience Advances Clinical Trials and Financial Stability
Premium
Company Announcements
Vigil Neuroscience Advances Clinical Trials and Financial Stability
4M ago
Vigil Neuroscience reports Q1 EPS (49c) vs. (50c) last year
Premium
The Fly
Vigil Neuroscience reports Q1 EPS (49c) vs. (50c) last year
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100